Last reviewed · How we verify
NCT03525106
Positive Psychology Intervention to Improve Quality of Life in Stem Cell Transplant Survivors and Their Caregivers
NA trial testing Booklet in Hematopoietic Cell Transplantation Recipient in 29 participants. Completed in 1 March 2020.
1 March 2020
Quick facts
| Lead sponsor | Fred Hutchinson Cancer Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 29 |
| Start date | 18 May 2018 |
| Primary completion | 1 March 2020 |
| Estimated completion | 1 March 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Booklet
- Exercise Intervention
- Quality-of-Life Assessment
- Survey Administration
- Telephone-Based Intervention
Conditions studied
- Hematopoietic Cell Transplantation Recipient — all drugs for Hematopoietic Cell Transplantation Recipient →
Sponsor
Fred Hutchinson Cancer Center — full company profile →
Who can join
18 and older, any sex, with Hematopoietic Cell Transplantation Recipient. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This trial studies a positive psychology intervention designed to improve quality of life in stem cell transplant survivors and their caregivers. Positive psychology (PP) uses systematic exercises (e.g., gratitude letters, acts of kindness) to potentially boost levels of optimism, resilience, and life enjoyment. PP interventions are often enjoyable, easy to understand, and can be delivered via telephone. PP intervention may improve the quality of life of participants who have undergone a stem cell transplant or their caregivers.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03525106
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Booklet
Trials testing the same drug.
- NCT06132854 — VR Based Simulation in the Preparation of Children for MRI - MRVR · NA · recruiting
- NCT05908357 — Study of Two Exercises Protocols for Autism Spectrum Disorder · NA · completed
- NCT05437666 — Effects of Pelvic Floor Health Education Program in Women With Stress Urinary Incontinence · NA · unknown
- NCT03301428 — Educational Tools to Improve Beliefs About Pain and Reduce Pain-related Disability · NA · completed
- NCT03187951 — PancFit: Multimodal Exercise During Preoperative Therapy for Pancreatic Cancer · NA · active not recruiting
Other recruiting trials for Hematopoietic Cell Transplantation Recipient
Currently open trials in the same condition.
- NCT02420860 — Elotuzumab and Lenalidomide After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma · Phase 2 · active not recruiting
- NCT00736749 — Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies · active not recruiting
Other Fred Hutchinson Cancer Center trials
Trials by the same sponsor.
- NCT07390968 — Self-Amplifying mRNA COVID-19 Vaccine (LUNAR-COV19) Versus Comirnaty Vaccine in Adult Hematopoietic Cell Transplant Pati · Phase 2 · not yet recruiting
- NCT07493252 — A Behavioral Application for Improving Smoking Cessation Among Smokers · NA · not yet recruiting
- NCT07490860 — A Restorative Justice-Based Lung Cancer Screening Decision-Making Support Intervention Tailored for Black Individuals to · NA · not yet recruiting
- NCT07194980 — Nemtabrutinib and Lisocabtagene Maraleucel for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small L · Phase 2 · not yet recruiting
- NCT07176000 — Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington S · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03525106 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fred Hutchinson Cancer Center
- Last refreshed: 4 March 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03525106.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing